atherosclerosis l-carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE−/− transgenic mice expressing CETP Frontiers | Gut Metabolite Trimethylamine-N-Oxide
Frontiers Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism Gut Microbiota and Its Metabolites in Atherosclerosis Development Figure 2 from The origin of trimethylamine N oxide (TMAO) and its role in development of atherosclerosis Semantic Scholar
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



